Syncona Portfolio
Latest statistics and disclosures from Syncona Portfolio's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AUTL, ACHL, Freeline Therapeutics Hldgs, ADAP, and represent 100.00% of Syncona Portfolio's stock portfolio.
- Syncona Portfolio has $158M in assets under management (AUM), dropping by 135.03%.
- Central Index Key (CIK): 0001725042
Tip: Access up to 7 years of quarterly data
Positions held by Syncona Portfolio consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Syncona Portfolio
Syncona Portfolio holds 4 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Autolus Therapeutics Spon Ads (AUTL) | 87.1 | $138M | 21M | 6.44 |
|
|
| Achilles Therapeutics Sponsored Ads (ACHL) | 6.2 | $9.9M | 11M | 0.89 |
|
|
| Freeline Therapeutics Hldgs Sponsored Ads | 5.9 | $9.3M | 1.5M | 6.36 |
|
|
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.7 | $1.1M | 1.4M | 0.79 |
|
Past Filings by Syncona Portfolio
SEC 13F filings are viewable for Syncona Portfolio going back to 2021
- Syncona Portfolio 2023 Q4 filed Feb. 1, 2024
- Syncona Portfolio 2023 Q3 filed Nov. 1, 2023
- Syncona Portfolio 2023 Q2 filed July 27, 2023
- Syncona Portfolio 2023 Q1 filed May 12, 2023
- Syncona Portfolio 2022 Q4 filed Feb. 14, 2023
- Syncona Portfolio 2022 Q3 filed Nov. 4, 2022
- Syncona Portfolio 2022 Q2 filed Aug. 10, 2022
- Syncona Portfolio 2022 Q1 filed May 31, 2022
- Syncona Portfolio 2021 Q4 filed Feb. 11, 2022